HuMax-CD32b

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHuMax-CD32b
Drug Alias NameCD32b checkpoint inhibitor (Genmab)FcgRIIb checkpoint inhibitor (Genmab)CD32b-targeting human IgG1-k antibody (Genmab)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionLow affinity immunoglobulin gamma Fc region receptor II-b antagonists
TargetsLow affinity immunoglobulin gamma Fc region receptor II-b
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenmab A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenmab A/S
Active IndicationsN/A
Inactive IndicationsLymphoma, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A